Bartlett & Co’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $23.5M | Buy |
215,001
+3,723
| +2% | +$386K | 0.38% | 59 |
|
|
2023
Q3 | $21.9M | Sell |
211,278
-9,720
| -4% | -$1.05M | 0.39% | 61 |
|
|
2023
Q2 | $25.7M | Buy |
220,998
+38,871
| +21% | +$4.41M | 0.44% | 60 |
|
|
2023
Q1 | $19.5M | Buy |
182,127
+7,624
| +4% | +$823K | 0.38% | 65 |
|
|
2022
Q4 | $19.5M | Sell |
174,503
-328
| -0.2% | -$33.5K | 0.39% | 66 |
|
|
2022
Q3 | $15.2M | Buy |
174,831
+659
| +0.4% | +$58.8K | 0.33% | 71 |
|
|
2022
Q2 | $16M | Sell |
174,172
-1,437
| -0.8% | -$127K | 0.32% | 72 |
|
|
2022
Q1 | $14.5M | Sell |
175,609
-2,333
| -1% | -$184K | 0.25% | 83 |
|
|
2021
Q4 | $13.8M | Buy |
177,942
+17,419
| +11% | +$1.39M | 0.23% | 84 |
|
|
2021
Q3 | $12.1M | Buy |
160,523
+6,697
| +4% | +$509K | 0.23% | 84 |
|
|
2021
Q2 | $12M | Sell |
153,826
-11,042
| -7% | -$821K | 0.23% | 84 |
|
|
2021
Q1 | $12.1M | Buy |
164,868
+398
| +0.2% | +$29.4K | 0.24% | 81 |
|
|
2020
Q4 | $12.8M | Sell |
164,470
-1,161
| -0.7% | -$88.8K | 0.27% | 75 |
|
|
2020
Q3 | $13.1M | Buy |
165,631
+347
| +0.2% | +$27.2K | 0.31% | 71 |
|
|
2020
Q2 | $12.2M | Sell |
165,284
-25
| -0% | -$1.88K | 0.32% | 73 |
|
|
2020
Q1 | $12.1M | Buy |
+165,309
| New | +$13M | 0.37% | 70 |
|
|
2019
Q3 | $13.8M | Buy |
171,396
+70,710
| +70% | +$5.67M | 0.36% | 73 |
|
|
2019
Q2 | $8.06M | Buy |
100,686
+6,572
| +7% | +$503K | 0.3% | 71 |
|
|
2019
Q1 | $7.47M | Sell |
94,114
-1,046
| -1% | -$78.2K | 0.29% | 73 |
|
|
2018
Q4 | $6.94M | Sell |
95,160
-1,896
| -2% | -$134K | 0.3% | 73 |
|
|
2018
Q3 | $6.57M | Buy |
97,056
+588
| +0.6% | +$37.5K | 0.25% | 81 |
|
|
2018
Q2 | $5.59M | Buy |
96,468
+3,415
| +4% | +$193K | 0.23% | 80 |
|
|
2018
Q1 | $4.84M | Buy |
93,053
+9,921
| +12% | +$536K | 0.2% | 84 |
|
|
2017
Q4 | $4.46M | Buy |
83,132
+228
| +0.3% | +$12.6K | 0.18% | 89 |
|
|
2017
Q3 | $5.07M | Buy |
82,904
+4,223
| +5% | +$256K | 0.21% | 86 |
|
|
2017
Q2 | $4.81M | Sell |
78,681
-482
| -0.6% | -$29.3K | 0.22% | 86 |
|
|
2017
Q1 | $4.8M | Sell |
79,163
-513
| -0.6% | -$31.1K | 0.22% | 85 |
|
|
2016
Q4 | $4.48M | Sell |
79,676
-849
| -1% | -$49.7K | 0.21% | 88 |
|
|
2016
Q3 | $4.79M | Sell |
80,525
-1,494
| -2% | -$87.4K | 0.23% | 83 |
|
|
2016
Q2 | $4.51M | Buy |
82,019
+4,370
| +6% | +$233K | 0.22% | 85 |
|
|
2016
Q1 | $3.92M | Sell |
77,649
-2,636
| -3% | -$129K | 0.2% | 85 |
|
|
2015
Q4 | $4.05M | Buy |
80,285
+471
| +0.6% | +$23.7K | 0.21% | 88 |
|
|
2015
Q3 | $3.76M | Buy |
79,814
+3,092
| +4% | +$164K | 0.21% | 88 |
|
|
2015
Q2 | $4.17M | Buy |
76,722
+780
| +1% | +$43.7K | 0.21% | 87 |
|
|
2015
Q1 | $4.17M | Sell |
75,942
-1,321
| -2% | -$74.8K | 0.21% | 86 |
|
|
2014
Q4 | $4.19M | Sell |
77,263
-386
| -0.5% | -$21.5K | 0.2% | 87 |
|
|
2014
Q3 | $4.39M | Sell |
77,649
-4,565
| -6% | -$256K | 0.21% | 88 |
|
|
2014
Q2 | $4.54M | Buy |
82,214
+1,883
| +2% | +$103K | 0.22% | 87 |
|
|
2014
Q1 | $4.35M | Sell |
80,331
-2,793
| -3% | -$145K | 0.22% | 85 |
|
|
2013
Q4 | $3.97M | Sell |
83,124
-3,752
| -4% | -$172K | 0.2% | 83 |
|
|
2013
Q3 | $3.95M | Sell |
86,876
-3,988
| -4% | -$182K | 0.21% | 83 |
|
|
2013
Q2 | $4.03M | Buy |
+90,864
| New | +$4.06M | 0.22% | 82 |
|
Other funds holding MRK
Bartlett & Co's MRK Position: Q4 2023 in Review
Bartlett & Co increased its Merck (MRK) stake by 1.8% in Q4 2023, buying an estimated $386K and bringing the position to 215,001 shares worth $23.5M. The position accounts for 0.38% of the portfolio, ranked #59.
Bartlett & Co first reported a position in MRK in Q2 2013 and has held it in 42 quarters since. The position peaked at $25.7M in Q2 2023. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.
- Bartlett & Co held 215,001 shares of Merck worth $23.5M as of Q4 2023.
- Bartlett & Co bought 3,723 Merck shares in Q4 2023, an estimated $386K.
- Merck made up 0.38% of Bartlett & Co's portfolio in Q4 2023, its #59 holding.
- Bartlett & Co first reported a position in Merck in Q2 2013 and has held it in 42 quarters since.
- Bartlett & Co's Merck position peaked at $25.7M in Q2 2023.
- 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.